Growth hormone therapy in patients with Noonan syndrome

Noonan syndrome (NS) is an autosomal dominant disorder that involves multiple organ systems, with short stature as the most common presentation (>70%). Possible mechanisms of short stature in NS include growth hormone (GH) deficiency, neurosecretory dysfunction, and GH resistance. Accordingly, GH...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Go Hun, Yoo, Han-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Pediatric Endocrinology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312920/
https://www.ncbi.nlm.nih.gov/pubmed/30599478
http://dx.doi.org/10.6065/apem.2018.23.4.176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312920/
https://www.ncbi.nlm.nih.gov/pubmed/30599478
http://dx.doi.org/10.6065/apem.2018.23.4.176

Ejemplares similares